FIELD: medicine, therapy, pulmonology.
SUBSTANCE: the present innovation deals with predicting the development chronic obstructive pulmonary disease (COPD) in smoking persons. It is necessary to detect clinical symptoms and risk factors out of life anamnesis: the index of packs/yr - A1; smoking intensity degree - A2; the number of cigarettes smoked out daily - A3; what cigarette are smoked out - A4; the experience of smoking in years - A5; the availability of dyspnea or crepitation - A6; how much has been smoked out against the cigarette's length - A7; whether the quantity of smoked out cigarettes has been changed during the last years - A8; inhalation of cigarette smoke - A9; the availability of sputum - A10; how often sputum is separated - A11; the degree of nicotinic addiction in points by Fagerstrem's test - A12 to establish their digital values and determine prognostic coefficients F1, F2, F3 by the following formulas: F1=-3.04-0.23*A1-2.11*A2-2.57*A3-0.60*A4-0.97*A5+0.44*A6-0.37*A7+0.19*A8+0.28*A9+0.16*A10-0.08*A11+0.29*A12; F2=-1.82-2.03*A1+1.45*A2+2.61*A3-0.17*A4+1.64*A5-0.29*A6+0.29*A7-0.19*A8-0.20*A9-0.16*A10-0.06*A11-0.49*A12; F3=-13.99+8.30*A1+3.08*A2+0.75*A3+3.04*A4-2.09*A5-0.71*A6+0.40*A7-0.08*A8-0.37*A9-0.02*A10+0.56*A11+0.64*A12. At F3 or F2 being above F1 one should predict high risk of COPD development, at F1 being above F2 or F3 one should predict low risk for COPD development. The innovation enables to evaluate the risk of COPD development more efficiently among smoking persons and simplify the method for its prediction.
EFFECT: higher accuracy and efficiency of prediction.
3 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTING THE DEVELOPMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN PATIENTS AT NO SIGNS OF BRONCHIAL OBSTRUCTION | 2005 |
|
RU2303956C1 |
METHOD OF PREDICTING RISK OF CHRONIC OBSTRUCTIVE LUNG DISEASE DEVELOPMENT IN PEOPLE WITH LONG SMOKING HISTORY | 2008 |
|
RU2359618C1 |
METHOD FOR PREDICTING ISCHEMIC CEREBRAL BLOOD CIRCULATION DISORDERS DEVELOPMENT IN MALE PATIENTS WITH ASYMPTOMATIC DEVELOPMENT OF ATHEROSCLEROTIC OCCLUSIVE DAMAGES IN MAIN ARTERIES OF THE HEAD | 1992 |
|
RU2068230C1 |
METHOD FOR PREDICTION OF CHRONIC CEREBRAL ISCHAEMIA DEVELOPMENT IN MEN WITH LIGHT AND MODERATE CHRONIC OBSTRUCTIVE LUNGS DISEASE WITHOUT CLINICAL IMPLICATIONS OF CEREBROVASCULAR PATHOLOGY | 2007 |
|
RU2347521C1 |
METHOD FOR PREDICTION OF VERTEBRAL FRACTURES IN WOMEN OF 60 YEARS AND OLDER | 2008 |
|
RU2381751C1 |
METHOD FOR PREDICTING REMOTE AFTEREFFECTS OF LIGHT CLOSE CRANIOCEREBRAL TRAUMA IN YOUNG PEOPLE | 2003 |
|
RU2246252C1 |
METHOD OF PREDICTING OF SEVERITY OF COURSE OF BRONCHIAL ASTHMA AT PERSONS OF YOUNG AGE | 2007 |
|
RU2340285C1 |
METHOD OF PREDICTING UNFAVOURABLE COURSE OF GASTROESOPHAGEAL REFLUX DISEASE | 2009 |
|
RU2407447C1 |
METHOD FOR PREDICTING THE DEVELOPMENT OF DISORDERS OF REPARATIVE OSSEOUS REGENERATION AND SURROUNDING SOFT TISSUES IN PATIENTS WITH MOTOR APPARATUS DISEASES | 2005 |
|
RU2300316C2 |
METHOD OF PREDICTING DEVELOPMENT OF DYSCIRCULATORY ENCEPHALOPATHY IN DIABETES MELLITUS PATIENTS HAVING NO CLINICAL MANIFESTATIONS OF CEREBRAL VASCULAR PATHOLOGY | 1997 |
|
RU2137125C1 |
Authors
Dates
2007-08-10—Published
2005-11-08—Filed